Literature DB >> 15140275

Dizziness.

Marianne Dieterich1.   

Abstract

BACKGROUND: The article gives an overview of the most frequent forms of vertigo, that are of peripheral-labyrinthine, central-vestibular, psychogenic, or physiologic origin. Dizziness or vertigo is a result of a mismatch between 3 sensory systems: the vestibular, the visual, and the somatosensory systems. These systems are mutually interactive and redundant in that orientation and balance are guided by simultaneous reafferent cues. The functional ranges of the systems overlap, thus permitting them to compensate in part for each other's deficiencies.
SUMMARY: Vertigo is not a well-defined disease entity, but rather a multisensory syndrome induced either by stimulation of the intact sensorimotor system by motion (eg, physiologic vertigo as in motion sickness or height vertigo), or by pathologic dysfunction of any of the stabilizing sensory systems (eg, peripheral vestibular as in vestibular neuritis, or central vestibular as in vertebro-basilar ischemia). The core region in vestibular vertigo syndromes is the vestibulo-ocular reflex, a 3-neuron arc that mediates the information of the semicircular canals and otoliths via the vestibular nerve and vestibular nucleus to the ocular motor nuclei (VI, IV, III) and the supranuclear integration centers in the ponto-mesencephalic brain stem.
CONCLUSIONS: Clinical phenomena characteristic for physiological and pathologic vertigo syndromes include postural, perceptual, oculomotor, and vegetative syndromes, which manifest with ataxia, nystagmus, vertigo, and nausea. Thus, the clinical testing must include examinations of postural, perceptual, oculomotor, and vegetative dysfunctions.

Entities:  

Mesh:

Year:  2004        PMID: 15140275     DOI: 10.1097/01.nrl.0000126586.29463.c8

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  4 in total

1.  Pharmacodynamic differentiation of lorazepam sleepiness and dizziness using an ordered categorical measure.

Authors:  Mohamed A Kamal; David E Smith; Jack Cook; Douglas Feltner; Allen Moton; Daniele Ouellet
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

2.  Mefloquine induces dose-related neurological effects in a rat model.

Authors:  G Dow; R Bauman; D Caridha; M Cabezas; F Du; R Gomez-Lobo; M Park; K Smith; K Cannard
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 3.  Current concepts and future approaches to vestibular rehabilitation.

Authors:  Fredrik Tjernström; Oz Zur; Klaus Jahn
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

4.  Vertigo/dizziness as a Drugs' adverse reaction.

Authors:  Serafina Chimirri; Rossana Aiello; Carmela Mazzitello; Laura Mumoli; Caterina Palleria; Mariolina Altomonte; Rita Citraro; Giovambattista De Sarro
Journal:  J Pharmacol Pharmacother       Date:  2013-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.